在运动性认知风险综合征的轻度认知障碍中,白质过强和更严重的认知功能障碍
Joon Hyuk Park1,2, Hyun Ju Yang1,3, Suyeon Park3
1Department of Psychiatry, Jeju National University School of Medicine, Jeju, Korea.
Journal of Korean medical science
|August 26, 2025
概括
轻度认知障碍患者的运动认知风险综合征 (MCRS) 与白质超强度 (WMH) 的增加有关. 识别MCRS有助于预测痴呆风险和理解认知能力下降.
科学领域:
- 神经学
- 老年病学
- 神经成像
背景情况:
- 运动认知风险综合症 (MCRS) 结合了慢步和认知问题.
- 一种基于运动的方法有助于识别患痴呆症高风险的个体.
研究的目的:
- 在轻度认知障碍 (MCI) 患者中研究白质强度 (WMH) 和MCRS之间的关系.
- 确定MCRS是否代表MCI群体中的一个独特的临床实体.
主要方法:
- 81名患有MCI的门诊患者接受了临床评估,体积脑MRI和神经心理测试.
- 使用3DMRI图像的自动细分来计算白质超强度 (WMH) 的体积.
- 认知问题和步行速度至少低于年龄和性别平均值的一个标准偏差定义了MCRS.
主要成果:
- 在MCRS和非MCRSMCI组中发现WMH体积和步行速度之间存在显著的负相关性.
- 在调整混因子后,年龄和WMH体积与MCRS显著相关.
- 与没有慢步的MCI患者相比,MCRS患者在记忆和认知测试中表现明显差.
结论:
- 在MCI群体中,MCRS是一个独立的临床实体.
- MCRS的特点是更大的认知障碍和增加的WMH负担.
- 这突显了MCI运动功能评估对预测认知能力下降的重要性.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


